Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine 4g QD vs BID in Active Ulcerative Colitis
NCT00737789Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Nov 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of Salcrozine in ulcerative colitis (UC), sponsored by Ferring Pharmaceuticals. Started Nov 2008; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00737789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00737789.